2,4-Dichloro-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine

Catalog No. :
ACXIZB482
CAS No. :
1227635-12-2
Molecular Formula :
C9H9Cl2N3
Molecular Weight :
230.10

IUPAC Name:2,4-dichloro-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine

2,4-Dichloro-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$120.00Login to see priceIn stockInquiry
5g95%$327.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dichloro-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine
IUPAC Name2,4-dichloro-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine
MDL No.MFCD23106265
Molecular FormulaC9H9Cl2N3
Molecular Weight230.10
SMILESCC(N1C=CC2=C(Cl)N=C(Cl)N=C21)C
InChI KeyCSWRJCCGUUJABM-UHFFFAOYSA-N
Synonym2,4-dichloro-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine;2,4-dichloro-7-(propan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine;7H-Pyrrolo[2,3-d]pyrimidine, 2,4-dichloro-7-(1-methylethyl)-
CAS No.1227635-12-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXIZB482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKYQT046 route compound structure diagram
    ACKYQT04690213-66-4 In Stock
  4. Then
  5. ACXIZB482 route product structure diagram
    ACXIZB4821227635-12-2 In Stock
Inquiry

2. ACXIZB482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKYQT046 route compound structure diagram
    ACKYQT04690213-66-4 In Stock
  4. Then
  5. ACXIZB482 route product structure diagram
    ACXIZB4821227635-12-2 In Stock
Inquiry

Comments (0)